In an animal study with APP/PS1 transgenic mice (a common mouse model for AD) [36], researchers showed that the denervation of the BF and, consequently, the cutoff from cholinergic innervation was followed by a rapid beta-amyloid deposition, the hallmark neuropathological marker for AD [37]. This evidence concerns the gene APP and Alzheimer disease.